US experts recommend Moderna booster for older and at-risk groupson October 15, 2021 at 2:13 am

The opinion submitted by the advisory committee of the Food and Drug Administration — composed of researchers, epidemiologists and infectious disease experts — is not binding, but it is rare for the FDA not to follow it.The opinion submitted by the advisory committee of the Food and Drug Administration — composed of researchers, epidemiologists and infectious disease experts — is not binding, but it is rare for the FDA not to follow it.Read MoreMoneycontrol Latest News

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: